A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age

Clinical trial NCT05900154 · COMPLETED

Trial details

NCT number: NCT05900154
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

RESPIRATORY SYNCYTIAL VIRUS (RSV)

Start date: 2023-06-22
Primary completion: 2024-02-29
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.